Further in this study, it has been shown that ESRP1 is epigenetically silenced in human melanoma brain metastasis, and high expression of CD44 containing exon v6 in early stages is a significant predictor of melanoma brain metastasis development (Marzese et al., 2015). Here, ESRP1 is linked to melanoma.